Jim Simons Vaxart, Inc. Transaction History
Renaissance Technologies LLC
- $70.6 Billion
- Q3 2025
Shares
16 transactions
Others Institutions Holding VXRT
# of Institutions
44Shares Held
6.06MCall Options Held
50.3KPut Options Held
0-
Marshall Wace, LLP London, X01.95MShares$722,6230.0% of portfolio
-
Black Rock Inc. New York, NY1.77MShares$656,5080.0% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL236KShares$87,3810.0% of portfolio
-
Iht Wealth Management, LLC Chicago, IL229KShares$84,8960.0% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL188KShares$69,7020.0% of portfolio
About Vaxart, Inc.
- Ticker VXRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,506,000
- Market Cap $46.8M
- Description
- Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...